ContextAlthough partner violence screening has been endorsed by many health organizations, there is insufficient evidence that it has beneficial health outcomes.

Objective

To determine the effect of computerized screening for partner violence plus provision of a partner violence resource list vs provision of a partner violence list only on women's health in primary care settings, compared with a control group.

Design, Setting, and Participants

A 3-group blinded randomized controlled trial at 10 primary health care centers in Cook County, Illinois. Participants were enrolled from May 2009-April 2010 and reinterviewed 1 year (range, 48-56 weeks) later. Participants were English- or Spanish-speaking women meeting specific inclusion criteria and seeking clinical services at study sites. Of 3537 women approached, 2727 were eligible, 2708 were randomized (99%), and 2364 (87%) were recontacted 1 year later. Mean age of participants was 39 years. Participants were predominantly non-Latina African American (55%) or Latina (37%), had a high school education or less (57%), and were uninsured (57%).

Intervention

Randomization into 3 intervention groups: (1) partner violence screen (using the Partner Violence Screen instrument) plus a list of local partner violence resources if screening was positive (n = 909); (2) partner violence resource list only without screen (n = 893); and (3) no-screen, no-partner violence list control group (n=898).

Main Outcome Measures

Quality of life (QOL, physical and mental health components) was the primary outcome, measured on the 12-item Short Form (scale range 0-100, mean of 50 for US population).

Results

At 1-year follow-up, there were no significant differences in the QOL physical health component between the screen plus partner violence resource list group (n = 801; mean score, 46.8; 95% CI, 46.1-47.4), the partner violence resource list only group (n = 772; mean score, 46.4; 95% CI, 45.8-47.1), and the control group (n = 791; mean score, 47.2; 95% CI, 46.5-47.8), or in the mental health component (screen plus partner violence resource list group [mean score, 48.3; 95% CI, 47.5-49.1], the partner violence resource list only group [mean score, 48.0; 95% CI, 47.2-48.9], and the control group [mean score, 47.8; 95% CI, 47.0-48.6]). There were also no differences between groups in days unable to work or complete housework; number of hospitalizations, emergency department, or ambulatory care visits; proportion who contacted a partner violence agency; or recurrence of partner violence.

Conclusions

Among women receiving care in primary care clinics, providing a partner violence resource list with or without screening did not result in improved health.

Trial Registration

clinicaltrials.gov Identifier: NCT00526994"/> Effect of Screening for Partner Violence on Women's Quality of LifeA Randomized Controlled Trial | JAMA | The JAMA Network
www.fgks.org   »   [go: up one dir, main page]

[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Figure. Study Diagram
Figure. Study Diagram

aOf the 7 women for whom the computer did not save baseline data, 2 were in the group that received partner violence screening plus a partner violence resource list, 1 was in the received partner violence resource list only group, and 4 were in the control group; the 1 patient who withdrew was also in the group that received partner violence screening plus a partner violence resource list.
bThere were 174 women in this group who screened positive.

Table 1. Demographic Characteristics and Baseline Scores of All Participants Enrolled by Group
Table 1. Demographic Characteristics and Baseline Scores of All Participants Enrolled by Group
Table 2. Adjusted QOL, Days Lost, Use of Health and Partner Violence Resource List or Services, and Partner Violence Recurrence at 1-Year Follow-up Among All Participantsa
Table 2. Adjusted QOL, Days Lost, Use of Health and Partner Violence Resource List or Services, and Partner Violence Recurrence at 1-Year Follow-up Among All Participantsa
Table 3. Adjusted QOL, Days Lost, Use of Health and Partner Violence Resource List or Services, and Partner Violence Recurrence at 1-Year Follow-up Among All Enrolled Women Based on Multiple Imputation of Missing Outcome Dataa
Table 3. Adjusted QOL, Days Lost, Use of Health and Partner Violence Resource List or Services, and Partner Violence Recurrence at 1-Year Follow-up Among All Enrolled Women Based on Multiple Imputation of Missing Outcome Dataa
Table 4. Adjusted QOL, Days Lost, Use of Health and Partner Violence Resource List or Services, and Partner Violence Recurrence at 1-Year Follow-up Among Women Experiencing Partner Violence in Year Before Enrollmenta
Table 4. Adjusted QOL, Days Lost, Use of Health and Partner Violence Resource List or Services, and Partner Violence Recurrence at 1-Year Follow-up Among Women Experiencing Partner Violence in Year Before Enrollmenta
1.
Council on Scientific Affairs, American Medical Association.  Violence against women—relevance for medical practitioners.  JAMA. 1992;267(23):3184-3189PubMedArticle
2.
American Public Health Association.  Position paper 9211 (PP): domestic violence. Washington, DC: APHA Public Policy Statements American Public Health Association; 1992
3.
Saltzman LE, Green YT, Marks JS, Thacker SB. Violence against women as a public health issue.  Am J Prev Med. 2000;19(4):325-329PubMedArticle
4.
American Medical Association.  H-515.965. Family and intimate partner violence. American Medical Association. http://www.ama-assn.org/ama1/pub/upload/mm/PolicyFinder/policyfiles/HnE/H-515.965.HTM. 2011. Accessed October 20, 2011
5.
The AAFP Commission on Special Issues and Clinical Interests.  Family violence: an AAFP white paper.  Am Fam Physician. 1994;50(8):1636-1640, 1644-1646PubMed
6.
Thackeray JD, Hibbard R, Dowd MD.Committee on Child Abuse and Neglect; Committee on Injury, Violence, and Poison Prevention.  Intimate partner violence: the role of the pediatrician.  Pediatrics. 2010;125(5):1094-1100PubMedArticle
7.
American College of Emergency Physicians.  Emergency medicine and domestic violence.  Ann Emerg Med. 1995;25(3):442-443PubMed
8.
American Congress of Obstetricians and Gynecologists (ACOG).  Screening tools—domestic violence. http://www.acog.org/About_ACOG/ACOG_Departments/Violence_Against_Women/Screening_Tools_Domestic_Violence. 2011. Accessed June 27, 2012
9.
American College of Nurse Midwives.  Position statement on violence against women. Washington, DC: American College of Nurse Midwives; 1997
10.
American Nursing Association.  Social causes and health care. American Nursing Association, March 24, 2000. http://ana.nursingworld.org/MainMenuCategories/HealthcareandPolicyIssues/ANAPositionStatements/social.aspx. Accessed June 27, 2012
11.
Joint Commission on Accreditation of Healthcare Organizations.  Accreditation Manual for Hospitals : Vol 1- Standards. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 1992; 21-22
12.
Committee on Preventive Services for Women, Institute of Medicine.  Clinical Preventive Services for Women: Closing the Gaps. Washington, DC: National Academy of Sciences; 2011:102-107
13.
US Preventive Services Task Force.  Screening for family and intimate partner violence: recommendation statement.  Ann Intern Med. 2004;140(5):382-386PubMedArticle
14.
Wathen CN, MacMillan HL. Interventions for violence against women: scientific review.  JAMA. 2003;289(5):589-600PubMedArticle
15.
Ramsay J, Richardson J, Carter YH, Davidson LL, Feder G. Should health professionals screen women for domestic violence? systematic review.  BMJ. 2002;325(7359):314-318PubMedArticle
16.
Runyan DK. Universal precautions for domestic violence. BMJ. 2002. http://www.bmj.com/rapid-response/2011/10/29/universal-precautions-domestic-violence. Accessed June 27, 2012
17.
Feldhaus KM, Koziol-McLaine J, Amsbury HL, Norton IM, Lowenstein SR, Abbott JT. Accuracy of 3 brief screening questions for detecting partner violence in the emergency department.  JAMA. 1997;277(17):1357-1361PubMedArticle
18.
Casteel C, Sadowski L. Intimate partner violence towards women. Clin Evid. 2010;1013. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907621/
19.
Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF-12v2 Health Survey. Lincoln, RI: QualityMetric Inc; 2002
20.
Tjaden P, Thoennes N. Full Report of the Prevalence, Incidence, and Consequences of Violence Against Women. Findings From the National Violence Against Women Survey. Washington, DC: National Institute of Justice; 2000
21.
Bauer HM, Rodríguez MA, Pérez-Stable EJ. Prevalence and determinants of intimate partner abuse among public hospital primary care patients.  J Gen Intern Med. 2000;15(11):811-817PubMedArticle
22.
Richardson J, Coid J, Petruckevitch A,  et al.  Identifying domestic violence: cross-sectional study in primary care.  BMJ. 2002;324(7332):271-277PubMedArticle
23.
McCauley J, Kern DE, Kolodner K,  et al.  The “battering syndrome”: prevalence and clinical characteristics of domestic violence in primary care internal medicine practices.  Ann Intern Med. 1995;123(10):737-746PubMedArticle
24.
Gin NE, Rucker L, Frayne S, Cygan R, Hubbell FA. Prevalence of domestic violence among patients in three ambulatory care internal medicine clinics.  J Gen Intern Med. 1991;6(4):317-322PubMedArticle
25.
Ware JE Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.  Med Care. 1996;34(3):220-233PubMedArticle
26.
SPSS, Inc.  PASW Statistics 18, Release Version 18.0.0. Chicago, IL: SPSS Inc; 2009
27.
StataCorp.  Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2011
28.
Straus MA. Measuring intrafamily conflict and violence: The Conflict Tactics (CT) Scale.  J Marriage Fam. 1979;41(1):75-88ArticleArticle
29.
MacMillan HL, Wathen CN, Jamieson E,  et al;  McMaster Violence Against Women Research Group.  Screening for intimate partner violence in health care settings: a randomized trial.  JAMA. 2009;302(5):493-501PubMedArticle
30.
Kiely M, El-Mohandes AA, El-Khorazaty MN, Blake SM, Gantz MG. An integrated intervention to reduce intimate partner violence in pregnancy: a randomized controlled trial.  Obstet Gynecol. 2010;115(2 pt 1):273-283PubMedArticle
31.
Tiwari A, Leung WC, Leung TW, Humphreys J, Parker B, Ho PC. A randomised controlled trial of empowerment training for Chinese abused pregnant women in Hong Kong.  BJOG. 2005;112(9):1249-1256PubMedArticle
Original Contribution
August 15, 2012

Effect of Screening for Partner Violence on Women's Quality of LifeA Randomized Controlled Trial

Author Affiliations

Author Affiliations: Centers for Disease Control and Prevention, Division of Violence Prevention, Atlanta, Georgia (Dr Klevens); Collaborative Research Unit, Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois (Drs Kee, Trick, and Sadowski, Ms Garcia, and Mr Angulo); and Depart ments of Obstetrics and Gynecology (Dr Jones), and Internal Medicine (Dr Sadowski), Rush University, Chicago, Illinois.

JAMA. 2012;308(7):681-689. doi:10.1001/jama.2012.6434
Abstract

Context Although partner violence screening has been endorsed by many health organizations, there is insufficient evidence that it has beneficial health outcomes.

Objective To determine the effect of computerized screening for partner violence plus provision of a partner violence resource list vs provision of a partner violence list only on women's health in primary care settings, compared with a control group.

Design, Setting, and Participants A 3-group blinded randomized controlled trial at 10 primary health care centers in Cook County, Illinois. Participants were enrolled from May 2009-April 2010 and reinterviewed 1 year (range, 48-56 weeks) later. Participants were English- or Spanish-speaking women meeting specific inclusion criteria and seeking clinical services at study sites. Of 3537 women approached, 2727 were eligible, 2708 were randomized (99%), and 2364 (87%) were recontacted 1 year later. Mean age of participants was 39 years. Participants were predominantly non-Latina African American (55%) or Latina (37%), had a high school education or less (57%), and were uninsured (57%).

Intervention Randomization into 3 intervention groups: (1) partner violence screen (using the Partner Violence Screen instrument) plus a list of local partner violence resources if screening was positive (n = 909); (2) partner violence resource list only without screen (n = 893); and (3) no-screen, no-partner violence list control group (n=898).

Main Outcome Measures Quality of life (QOL, physical and mental health components) was the primary outcome, measured on the 12-item Short Form (scale range 0-100, mean of 50 for US population).

Results At 1-year follow-up, there were no significant differences in the QOL physical health component between the screen plus partner violence resource list group (n = 801; mean score, 46.8; 95% CI, 46.1-47.4), the partner violence resource list only group (n = 772; mean score, 46.4; 95% CI, 45.8-47.1), and the control group (n = 791; mean score, 47.2; 95% CI, 46.5-47.8), or in the mental health component (screen plus partner violence resource list group [mean score, 48.3; 95% CI, 47.5-49.1], the partner violence resource list only group [mean score, 48.0; 95% CI, 47.2-48.9], and the control group [mean score, 47.8; 95% CI, 47.0-48.6]). There were also no differences between groups in days unable to work or complete housework; number of hospitalizations, emergency department, or ambulatory care visits; proportion who contacted a partner violence agency; or recurrence of partner violence.

Conclusions Among women receiving care in primary care clinics, providing a partner violence resource list with or without screening did not result in improved health.

Trial Registration clinicaltrials.gov Identifier: NCT00526994

Recognition of partner violence as a health1 and public health problem2,3 has led numerous professional410 and health care organizations,11 as well as the Institute of Medicine,12 to recommend screening (ie, testing asymptomatic patients to identify those requiring special intervention) or assessment of women for partner violence in primary care settings. However, the United States Preventive Services Task Force,13 the Canadian Task Force,14 and the United Kingdom's Health Technology Assessment Program15 have concluded there is insufficient evidence to support this recommendation.

Quiz Ref IDThe primary aim of this trial was to establish the effect of computerized partner violence screening and provision of local partner violence resource lists to women seeking care in outpatient clinical settings on women's quality of life (QOL). Days lost from work or household activities, use of health care and partner violence services, and the recurrence of partner violence were secondary outcomes. This trial also tested the effects of providing information on local partner violence resources to all women irrespective of women's disclosure of partner violence.16

Methods
Design and Setting

A 3-group parallel individually randomized controlled trial (1:1:1 ratio) was conducted in 10 primary health care clinics in Cook County, Illinois; 8 of these were public (4 community-based primary care and 4 in-hospital primary care clinics for prenatal, gynecological, family planning, and general medicine), and 2 were private (1 in-hospital adult obstetrics and gynecology clinic and 1 in-hospital adolescent obstetrics and family planning clinic).

Participants

Quiz Ref IDWomen seeking clinical services at the study sites were eligible if they were at least 18 years of age, spoke and understood English or Spanish, had access to a telephone, and would share contact information for at least 1 reliable phone number for follow-up. Women were excluded from participation if they were accompanied by their partner and could not be safely separated at the clinical enrollment site, were accompanied by a child older than 3 years without alternative adequate provision for child care, or were visually, hearing, or mentally impaired. Women were recruited from May 2009 until April 8, 2010.

Randomization Process and Description of Study Groups

After giving informed consent, participants were randomized into 1 of 3 study groups. The randomization procedure was built into the computer system that included the audio-computer-assisted self-interview (A-CASI) program, and the automated randomization procedure occurred after the participant was entered into the system. Participants were randomized using blocks of 30 (ie, 10/block) and stratified by clinical site, with allocation concealed from participants and research assistants. The Box shows descriptions of the study groups.

Box. Description of the 3 Study Groups

Screen Plus Partner Violence Resource List

Group in which women were screened by the audio–computer-assisted self-interview (A-CASI) using the Partner Violence Screen instrument.17 The Partner Violence Screen asks 3 questions:

   Have you been hit, kicked, punched, or otherwise hurt by someone within the past year?

   Do you feel safe in your current relationship?

   Is there a partner from a previous relationship who is making you feel unsafe now?

Women screening positive (affirmative response to ≥ 1 question) were shown a brief video on the computer screen in which a partner violence advocate provided support and information about the hospital-based partner violence advocacy program and encouraged the viewer to seek help. These women also received a computer printout of contact information for the local partner violence advocacy program, the local and national 24-hour hotlines, local battered women's shelters, and the local battered women's outreach program. For safety reasons, the partner violence resources were combined with a list of general resources (ie, health services, legal aid, parenting support, general counseling services, alcohol and drug treatment, and shelters for the homeless). Women screening negative received the list of general resources only.

Partner Violence Resource List Only

Group in which all women were given the partner violence resources and general resource list only—no screening.

Control Group

Group in which women were not screened and did not receive the partner violence resource list, but were given the list of general resources. Although not all of these resources have been rigorously evaluated, none on this general list has been shown to have health effects on women experiencing partner violence.18

Outcomes

Outcomes were assessed at the time of 1-year follow-up. QOL was the primary outcome and was assessed using the Short Form (SF-12) version 2.19 This instrument has 12 items measuring 8 subscales of mental and physical health during the past 4 weeks: general health, physical functioning, role limitations due to physical health problems, role limitations due to emotional problems, bodily pain, vitality (energy/fatigue), social functioning, and mental health (psychological distress). These subscales are combined to form a physical health composite scale and a mental health composite scale. Each scale is standardized to have a mean (SD) of 50 (10) for the US population with a possible range of 0 to 100; higher scores represent a better health state.

Days lost from work or household activities, use of health or partner violence services, and recurrence of partner violence were secondary outcomes. The days lost outcome was of self-reported days missed from work outside the home (if working) and days unable to do household tasks during the past 4 weeks. The use of health services outcome included the number of ambulatory and emergency department visits, and hospitalizations identified in participants' electronic medical records during the study period. Using a computerized query, electronic data for all encounters at the clinical sites of the county health care system were obtained for each participant for the 1-year study period following the date of study enrollment. The use of partner violence services outcome was women's self-reported actions related to the resource list they received at their recruitment visit. Specifically, women were asked at the 1-year follow-up interview: (1) if they remembered receiving a printout of a list of services that provides help for women; (2) whether they had shared it with anyone; (3) whether they had contacted any of the services; and (4) whether they had called or visited an agency that provides services for women experiencing partner violence.

Recurrence of partner violence was established by first asking women if they had ever experienced any of 18 situations adapted from the National Violence Against Women Survey.20 Three situations concerned psychological abuse (eg, put downs, shouting, or swearing), 4 concerned partners' controlling behaviors (eg, controlling access to family, friends, or income; jealousy), 8 concerned physical aggression without a weapon (eg, pushing, slapping, kicking, hitting with an object, choking), 2 concerned threat or assault with a gun or knife, and 1 concerned forced vaginal, oral, or anal sex. Positive response to any question was considered as experiencing partner violence. Next, women experiencing partner violence were asked if any of these situations had occurred in the past year or in the year before study enrollment. Recurrence was then calculated as the percentage of women reporting partner violence in the year before enrollment who also reported partner violence in the past year.

Data Collection

Trained research assistants approached potential participants in each clinic's waiting room to determine their interest and eligibility and obtain written consent. Research assistants then accompanied participants to private rooms or kiosks equipped with touch-screen computers and headphones and started the A-CASI. The mean (SD) length of the A-CASI was 17.5 minutes (5.1). Quiz Ref IDAfter completing the A-CASI, research assistants asked participants their age, level of education, insurance status, and racial/ethnic group, and then negotiated safe follow-up contact times and telephone numbers, a safe message to leave on an answering machine, a code word participants could use if interrupted during the follow-up interview, and an address for receiving a reminder letter and money order. Participants were given $20 as compensation for the baseline interview and a $15 money order for the follow-up interview.

The 1-year follow-up was conducted using a Computer-Assisted Telephone Interview (CATI). One month before the follow-up, the research assistants reminded participants of the upcoming interview and updated their contact information using mailed reminder letters, calls to women and their contacts, public access jail and death websites, and surveillance of the electronic appointment system. Research assistants attempted to complete follow-up interviews during the times negotiated with women at baseline. The median (range)) number of attempts to locate women for follow-ups was 4 (1-59). All CATIs were conducted between 48 and 56 weeks after the women enrolled by staff blinded to the study group assignment.

This study protocol was approved by the institutional review boards at the Centers for Disease Control and Prevention (CDC), the Cook County Hospital and Health Services, and Rush Medical University.

Analysis

Descriptive statistics were used to compare demographic and baseline characteristics of participants between study groups for all women enrolled and for the subgroup of women experiencing partner violence in the year prior to enrollment. An intent-to-treat method using complete case analysis was used to compare outcomes among all women and among the subgroup of women experiencing partner violence in the year prior to enrollment.

χ2 Tests (for categorical variables) or F ratios (for comparing means) were used to establish statistically significant differences between study groups at baseline and at follow-up for each outcome, with the intervention group as the independent variable and without adjusting for covariates. Since adding partner violence screening to the health care encounter comes with the downside of reduced efficiency, demonstrating superiority was the goal of this study. Significance tests were used to determine whether screening along with provision of information on partner violence resources would be better than no screen and no information on partner violence resources. A sample size of 115 women experiencing partner violence in each group (or 885/group if the prevalence of past-year partner violence in a primary care sample is 13%2124) would provide 85% power to detect an effect size of 0.4, which is equivalent to 4 points in the QOL increase of 4 points in the means of QOL physical health and mental health component scores with a 1-tailed test (as specified in the protocol) at α = .05. Differences of 9 points on the physical and 17 points on the mental health components of the QOL scales differentiated patients with known serious vs minor physical and mental health problems.25

Multilevel linear regression models were used to estimate the effects of intervention on the mean scores of QOL scales, days lost, number of emergency department and ambulatory care visits, and hospitalizations, while adjusting for confounders and the clustering of the data by clinic. For each outcome, the mixed models linear command of SPSS (version 18)26 was selected with the enrollment clinic specified as subjects and as a random intercept with variance components as the covariance structure to adjust for clustering by clinic; the intervention group was specified as a factor; baseline scores (only QOL scales and days lost) of each outcome, age, education, race/ethnicity, and health care insurance status were entered as covariates; and maximum likelihood was entered as the estimation procedure. Intervention group and covariates were treated as fixed effects. Results are presented as estimated marginal means and 95% CIs are adjusted using the Bonferroni correction. The GLLAMM procedure in Stata (version 12)27 was used for the 5 dichotomous outcomes (remembering the list, use of the list, sharing the list, contacting a partner violence agency, and recurrence of partner violence) by specifying the link function as logit, the distribution of the outcome variable as fam (binom), the clinic as the level 2 variable; and age, education, race/ethnicity, and health care insurance status entered as covariates. To account for missing data due to loss to follow-up or exclusion from the county's electronic medical record system, adjusted means and odds ratios were estimated from 5 complete files generated through multiple imputation to test the robustness of the observed findings for all enrolled women.

Results

The Figure shows sample recruitment, allocation, and retention. Of 3537 women approached, 77% (2727) met eligibility criteria and 76% (2708) were randomized to 1 of 3 study groups and assessed. The mean (SD) age of enrolled women was 38.7 (14.9) years. Enrolled women were predominantly non-Latina African American (54.9%; 1482) or Latina (36.8%; 993), had a high school education or less (56.5%; 1527), and were uninsured (57%; 1532), with no significant differences between study groups (Table 1).

One year after enrollment, 87.2% (2364/2708) of the women completed the follow-up interview, with no differences in retention by study group. Women lost to follow-up at 1 year were 5 years younger (P < .001), more likely to have public insurance (44.9% vs 33.8%; P < .001), and fewer had higher education (39% vs 44%; P = .005) than women who completed the follow-up.

There were minimal differences in outcomes between the unadjusted and the adjusted estimates and therefore, only adjusted estimates are presented in Table 2. For our primary outcome at the 1-year follow-up, mean scores on the QOL components and subscales ranged from 44 to 52 among all women, with no statistically significant differences by study group status for any of the components or subscales. For our secondary outcomes, women reported losing 0.7 days of work (95% CI, 0.5-0.8) and 2.0 days of household activities (95% CI, 1.8-2.2), with no significant differences in number of days lost between study groups. The mean number of hospitalizations and emergency department and ambulatory care visits were 0.2 (95% CI, 0-0.3), 0.3 (95% CI, 0.2-0.4), and 5.7 (95% CI, 4.1-7.2) in the year following enrollment, with no statistically significant differences between study groups. At follow-up, 66.5% (1574/2364) remembered receiving the list of referral resources. Among those who remembered receiving the list, 32.9% (519/1574) shared the list with someone, but only 6.3% (100/1574) of all women used the list to contact services, and fewer than 4.4% (106/2362) contacted an agency that provides help to women hurt by a partner. At follow-up, 9.9% (235/2362) reported experiencing partner violence in the year before enrolling in the study and in the previous year (recurrence), with no statistically significant differences between study groups. Estimates derived from multiple imputation (Table 3) were almost identical to the original results, with no significant differences for QOL scales or any of the secondary outcomes.

Subgroup Analysis of Women Experiencing Partner Violence in the Year Prior to Enrollment

Based on women's recall of partner violence experiences using 18 of the National Violence Against Women Survey20 questions, 14.6% (346/2364) reported experiencing partner violence in the year before enrolling in the study, with no significant differences between study groups. In comparison with the overall sample, this subgroup had lower scores on the baseline mental health composite (45.7 vs 41.5; P < .001) and on the role limitations due to emotional problems (42.8 vs 40.1; P < .001), social functioning (44.7 vs 41.5; P < .001), mental health (46.2 vs 42.6; P < .001), and vitality subscales (49.9 vs 48.2; P = .003).

Again, there were minimal differences in outcomes between the unadjusted and the adjusted estimates in these subgroup analyses, and therefore, only adjusted estimates are presented (Table 4). The adjusted mean scores on the QOL components and subscales ranged from 41.9 to 49.4 in this subgroup, with no statistically significant differences by study group status for any of the components or subscales. Women reported losing 0.9 days of work (95% CI, 0.5-1.2) and 2.5 days of housework (95% CI, 1.9-3.1) in the previous 4 weeks, with no statistically significant differences between study groups. The mean number of hospitalizations and emergency department and ambulatory care visits was 0.1 (95% CI, 0-0.3), 0.3 (95% CI, 0.2-0.4), and 5.0 (95% CI, 3.3-6.7) in the previous year with no statistically significant differences between study groups. Of women experiencing partner violence in the year prior to enrolling in the study, 72% (249/345) remembered receiving the list of referral resources. Of those women who remembered receiving the list, 33% (81/249) shared the list with someone but only 9% (23/249) used the list to contact services, and 14% (49/346) contacted an agency that provides help to women experiencing partner violence. Although women in the screen plus partner violence resource list group were almost twice as likely as the control group to share the list and contact an agency that provides help to women abused by a partner, none of the differences observed between study groups were statistically significant. The rate of recurrence among women experiencing partner violence before enrollment in the study was 68% (235/345), with no statistically significant differences between study groups.

Comment

Quiz Ref IDThis 3-group randomized controlled trial showed no differences in QOL indicators, number of days lost, hospitalizations, emergency department or ambulatory visits, use of partner violence resources, or recurrence of partner violence between women screened plus receiving a partner violence resource list, women only receiving a partner violence resource list (not screened), and women in a no-screen no-partner violence resource list control group. These nonsignificant differences were based on 1-tailed tests because this was conceived as a superiority trial. Results were not appreciatively different using 2-tailed tests.

Before discussing the potential implications of these findings, several limitations of the study must be considered. First are the potential sample biases. Although the participation rate was relatively high, we do not know whether nonparticipants differed from participants. In addition, the 12% lost to follow-up differed in age, education, and insurance status from those retained and although they may have differed in outcomes as well, estimates based on 5 imputed data files suggest that this would not have changed the findings. Generalizability of the findings is limited by the urban setting; exclusion of participants without phones, accompanied by partners or older children at the time of their visit, who were non-English or non-Spanish speaking; and the limited number of college-educated and white, Asian, or Native American participants in the sample.

A second limitation is the intensity of the intervention. Participants in the screening group were only screened once—perhaps screening once is insufficient for patients to disclose partner violence. Thus, it remains to be determined whether repeated screening might have an effect on women's health. Quiz Ref IDSimilarly, showing a video encouraging the use of referral resources along with a printed list of partner violence resources may also be considered too brief of an intervention to expect an v effect. Screening might be effective if combined with a stronger type of intervention.

The list of general resources provided to the control group might be considered an intervention. Some of these resources have not been rigorously evaluated, but to date, none of the interventions on this list have shown health effects among women experiencing partner violence.18 Although it is possible that some of these resources might affect health, this would not affect the results related to the partner violence screen and provision of resources.

Recall bias may be an issue for the subgroup analyses of women experiencing partner violence during the year before enrollment. In order to have a no-screen, no-partner violence resource list control group as well as a “partner violence resource list only” group, we did not ask all women about partner violence at baseline. Instead, we asked all women at the 1-year follow-up to recall if they had experienced any of 18 situations adapted from the National Violence Against Women Survey20 in the year prior to enrolling in the study (ie, 2 years ago). It is possible that some women may not have remembered experiencing partner violence 2 years earlier. Others may have mistaken the period of time when they actually experienced partner violence. However, because the same questions were asked in all 3 study groups with no significant differences in the proportion reporting partner violence in the year prior to enrollment between the study groups, these potential errors in classification are not believed to affect the findings. The use of items from National Violence Against Women Survey to distinguish this subgroup may also be questioned as these have not been validated. However, these items were adapted from the validated and widely used Conflict Tactics Scale.28

Conversely, this trial had several important strengths: random assignment, a true control group, small loss to follow-up, blinded assessment of outcomes, outcomes based on multiple information sources (self-reported health status and electronic medical records), a mix of both public and private clinics, and a large number (and proportion) of Latina participants (who are often excluded from studies because of language barriers).

The consistency of the results across the many outcomes examined also contributes to greater confidence in the findings. These findings are also consistent with another trial in primary care settings.29 Nonetheless, 2 recent trials among pregnant women showing effects on partner violence recurrence, preterm birth,30 and women's QOL31 raise the possibility that screening with more intensive interventions may be effective among pregnant women and on other types of outcomes such as preterm birth.

In conclusion, the results of this study suggest providing a partner violence resource list with or without computerized screening of female adult patients in primary care settings does not result in significant benefits in terms of general health outcomes. These findings provide important information for clinicians and others to consider in light of recent professional recommendations calling for routine screening.

Back to top
Article Information

Corresponding Author: Joanne Klevens, MD, PhD, 4770 Buford Hwy, Mailstop F-63, Atlanta, GA 30341 (jklevens@cdc.gov).

Author Contributions: Dr Klevens had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept: Klevens

Study design: Klevens, Key, Trick, Sadowski.

Acquisition of data: Kee, Garcia, Angulo, Jones, Sadowski.

Analysis and interpretation of data: Klevens, Kee, Trick, Sadowski.

Drafting of the manuscript: Klevens, Kee.

Critical revision of the manuscript for important intellectual content: Klevens, Kee, Trick, Garcia, Angulo, Jones, Sadowski.

Statistical analysis: Klevens, Trick.

Obtained funding: Klevens, Sadowski.

Administrative, technical, or material support: Trick, Garcia, Angulo, Jones, Sadowski.

Study supervision: Kee, Garcia, Angulo, Sadowski.

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sadowski reports receipt of consultancy fees from the World Health Organization. The other authors report no disclosures.

Funding/Support: This study was supported by the Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control, Division of Violence Prevention.

Role of the Sponsors: The CDC, National Center for Injury Prevention and Control, Division of Violence Prevention did participate in the design and conduct of the study; management, analysis, and interpretation of the data or preparation, review, and approval of the manuscript.

Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.

Online-only Content: The Author Video Interview is available

Additional Contributions: James Mercy, PhD, and Linda Saltzman†, PhD, CDC (†Deceased), for study concept, Drs Mercy and Saltzman received no compensation for their work on this article. Gladys Arana-Arriola, BA candidate, Gisselle Rodriguez, MEd, and Yazmin San Miguel, BS, DePaul University; Amalia Turkewitz, BA, George Washington University; Crystal Sanchez, BA, Loyola University; Marycarmen Hernandez, BA, Northern Illinois University; Maria Valdovinos, BA, Northwestern University; Emma Rubin, BA, Oberlin College; Emily McClure, MA, United Nations University; Celia Almazan, MSW, Kate Hawley, MSW, TaCarra Moore, MPH, Magdalena Nava, BA, Elizabeth Perez, MD, MPH, Maria Rodriguez Sanchez, MEd, and Claire Seryak, PhD, University of Illinois at Chicago; Yvette Castaneda, BS, and Maricarmen Herrera, BA, University of Illinois at Urbana-Champaign; and Andrea Larson, BS, and Mary Pawlek, MD, University of Wisconsin-Madison helped in recruitment, assessment, and follow-up of study participants and were financially compensated for their work. Stephanie Love Patterson, Illinois certified domestic violence professional, associate director of the Connections for Abused Women and their Children, Stroger Hospital's in-house partner violence advocacy program, helped develop the partner violence video shown to women screening positive (for a nominal sum); and Ashlesha Patel, MD, MPH, systems director of the Family Planning Services of Cook County Health and Hospital Systems, facilitated access to patients seeking services at the gynecological and family planning outpatient clinics at Stroger Hospital (received no compensation).

References
1.
Council on Scientific Affairs, American Medical Association.  Violence against women—relevance for medical practitioners.  JAMA. 1992;267(23):3184-3189PubMedArticle
2.
American Public Health Association.  Position paper 9211 (PP): domestic violence. Washington, DC: APHA Public Policy Statements American Public Health Association; 1992
3.
Saltzman LE, Green YT, Marks JS, Thacker SB. Violence against women as a public health issue.  Am J Prev Med. 2000;19(4):325-329PubMedArticle
4.
American Medical Association.  H-515.965. Family and intimate partner violence. American Medical Association. http://www.ama-assn.org/ama1/pub/upload/mm/PolicyFinder/policyfiles/HnE/H-515.965.HTM. 2011. Accessed October 20, 2011
5.
The AAFP Commission on Special Issues and Clinical Interests.  Family violence: an AAFP white paper.  Am Fam Physician. 1994;50(8):1636-1640, 1644-1646PubMed
6.
Thackeray JD, Hibbard R, Dowd MD.Committee on Child Abuse and Neglect; Committee on Injury, Violence, and Poison Prevention.  Intimate partner violence: the role of the pediatrician.  Pediatrics. 2010;125(5):1094-1100PubMedArticle
7.
American College of Emergency Physicians.  Emergency medicine and domestic violence.  Ann Emerg Med. 1995;25(3):442-443PubMed
8.
American Congress of Obstetricians and Gynecologists (ACOG).  Screening tools—domestic violence. http://www.acog.org/About_ACOG/ACOG_Departments/Violence_Against_Women/Screening_Tools_Domestic_Violence. 2011. Accessed June 27, 2012
9.
American College of Nurse Midwives.  Position statement on violence against women. Washington, DC: American College of Nurse Midwives; 1997
10.
American Nursing Association.  Social causes and health care. American Nursing Association, March 24, 2000. http://ana.nursingworld.org/MainMenuCategories/HealthcareandPolicyIssues/ANAPositionStatements/social.aspx. Accessed June 27, 2012
11.
Joint Commission on Accreditation of Healthcare Organizations.  Accreditation Manual for Hospitals : Vol 1- Standards. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 1992; 21-22
12.
Committee on Preventive Services for Women, Institute of Medicine.  Clinical Preventive Services for Women: Closing the Gaps. Washington, DC: National Academy of Sciences; 2011:102-107
13.
US Preventive Services Task Force.  Screening for family and intimate partner violence: recommendation statement.  Ann Intern Med. 2004;140(5):382-386PubMedArticle
14.
Wathen CN, MacMillan HL. Interventions for violence against women: scientific review.  JAMA. 2003;289(5):589-600PubMedArticle
15.
Ramsay J, Richardson J, Carter YH, Davidson LL, Feder G. Should health professionals screen women for domestic violence? systematic review.  BMJ. 2002;325(7359):314-318PubMedArticle
16.
Runyan DK. Universal precautions for domestic violence. BMJ. 2002. http://www.bmj.com/rapid-response/2011/10/29/universal-precautions-domestic-violence. Accessed June 27, 2012
17.
Feldhaus KM, Koziol-McLaine J, Amsbury HL, Norton IM, Lowenstein SR, Abbott JT. Accuracy of 3 brief screening questions for detecting partner violence in the emergency department.  JAMA. 1997;277(17):1357-1361PubMedArticle
18.
Casteel C, Sadowski L. Intimate partner violence towards women. Clin Evid. 2010;1013. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907621/
19.
Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF-12v2 Health Survey. Lincoln, RI: QualityMetric Inc; 2002
20.
Tjaden P, Thoennes N. Full Report of the Prevalence, Incidence, and Consequences of Violence Against Women. Findings From the National Violence Against Women Survey. Washington, DC: National Institute of Justice; 2000
21.
Bauer HM, Rodríguez MA, Pérez-Stable EJ. Prevalence and determinants of intimate partner abuse among public hospital primary care patients.  J Gen Intern Med. 2000;15(11):811-817PubMedArticle
22.
Richardson J, Coid J, Petruckevitch A,  et al.  Identifying domestic violence: cross-sectional study in primary care.  BMJ. 2002;324(7332):271-277PubMedArticle
23.
McCauley J, Kern DE, Kolodner K,  et al.  The “battering syndrome”: prevalence and clinical characteristics of domestic violence in primary care internal medicine practices.  Ann Intern Med. 1995;123(10):737-746PubMedArticle
24.
Gin NE, Rucker L, Frayne S, Cygan R, Hubbell FA. Prevalence of domestic violence among patients in three ambulatory care internal medicine clinics.  J Gen Intern Med. 1991;6(4):317-322PubMedArticle
25.
Ware JE Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.  Med Care. 1996;34(3):220-233PubMedArticle
26.
SPSS, Inc.  PASW Statistics 18, Release Version 18.0.0. Chicago, IL: SPSS Inc; 2009
27.
StataCorp.  Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2011
28.
Straus MA. Measuring intrafamily conflict and violence: The Conflict Tactics (CT) Scale.  J Marriage Fam. 1979;41(1):75-88ArticleArticle
29.
MacMillan HL, Wathen CN, Jamieson E,  et al;  McMaster Violence Against Women Research Group.  Screening for intimate partner violence in health care settings: a randomized trial.  JAMA. 2009;302(5):493-501PubMedArticle
30.
Kiely M, El-Mohandes AA, El-Khorazaty MN, Blake SM, Gantz MG. An integrated intervention to reduce intimate partner violence in pregnancy: a randomized controlled trial.  Obstet Gynecol. 2010;115(2 pt 1):273-283PubMedArticle
31.
Tiwari A, Leung WC, Leung TW, Humphreys J, Parker B, Ho PC. A randomised controlled trial of empowerment training for Chinese abused pregnant women in Hong Kong.  BJOG. 2005;112(9):1249-1256PubMedArticle
×